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Abstract: The available methodologies to estimate the obesity-attributable mortality fraction (OAMF)
affect the levels found and hamper the construction of time series. Our aim was to assess the
impact of using different techniques to estimate the levels and the trends in obesity-attributable
mortality for The Netherlands between 1981 to 2013. Using Body Mass Index (BMI), all-cause and
cause-specific mortality data, and worldwide and European relative risks (RRs), we estimated OAMFs
using three all-cause approaches (partially adjusted, weighted sum, and the two combined) and
one cause-of-death approach (Comparative Risk Assessment; CRA). We adjusted the CRA approach
to purely capture obesity (BMI ≥ 30 kg/m2). The different approaches led to a range of estimates.
The weighted sum method using worldwide RRs generated the lowest (0.9%) while the adjusted
CRA approach using 2013 RRs generated the highest estimate (1.5%). Using European-specific
RRs instead of worldwide RRs resulted in higher estimates. Most of the approaches revealed an
increasing OAMF over the period 1981 to 2013 especially from 1993 onwards except for the adjusted
CRA approach among women. Estimates of OAMF levels and trends differed depending on the
method applied. Given the limited available data, we recommend using the weighted-sum method
to compare obesity-attributable mortality across European countries over time.
Keywords: obesity; mortality; The Netherlands; estimation; CRA approach; partially adjusted
method; weighted sum method; population-attributable fraction
1. Introduction
Over the past three decades, the prevalence of obesity has risen tremendously across the globe [1]
to the point that it is now considered a pandemic [1,2]. Obesity constitutes a major health burden [3]
since there is evidence of strong links between obesity and life-threatening chronic diseases such as
type II diabetes, cardiovascular disease, stroke, and multiple types of cancer [4–6]. As a consequence,
the rise in obesity has led to recent declines in survival and life expectancy [7,8]. Because the health
burden associated with obesity is so significant, its estimation bears high relevance and importance.
In quantifying the health burden of obesity at the population level, the population attributable
fraction (PAF) is commonly used [2]. The PAF is defined as the proportion of total events (e.g., deaths)
in a population that could be prevented if a particular risk factor (e.g., obesity) could be eliminated [2].
The PAF combines information on the proportion of the population exposed to obesity (prevalence)
with the relative risk (RR) of dying from obesity [9].
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Over the years, many methodologies for estimating obesity-attributable mortality fractions
(OAMF) by means of different PAF formulas have been developed and range from approaches
that use RRs for all-cause mortality (all-cause approach) to more recent approaches that use RRs for
obesity-related causes of death (cause-of-death approach) (See Supplementary Material file 1). Within
the all-cause approach, there are various methods for estimating OAMF that require varying degrees
of data availability (see the Supplementary Material file 1). Thus, implementing some of these methods
can be difficult. The partially adjusted method [10–13], which multiplies the adjusted RR of dying from
obesity with the obesity prevalence in the studied population, is often used [14,15]. In the weighted
sum method, unadjusted RRs by age and sex (for instance) are commonly weighted by the obesity
prevalence within each subgroup [16]. The Comparative Risk Assessment (CRA) methodology, which
was recently developed by the Global Burden of Disease (GBD) Study, uses cause-specific mortality,
cause-specific RRs, and the population distribution of BMI to estimate cause-specific shares of mortality
due to a high BMI (≥23 kg/m2 [17]. Due to their focus on high BMI, the CRA estimates cannot be
readily compared with other estimates that focus strictly on obesity (BMI ≥ 30 kg/m2).
As previously published research has shown, estimates of obesity-attributable mortality vary
depending on which methodology is used [18]. For example, in 1991, the number of obesity-related
deaths in the United States was ~196,000 when the weighted sum method was used and was
~230,000 obesity-related deaths when the partially adjusted method was applied [15].
The use of different methods and the range of outcomes these methods generate not only cause
uncertainty about the true population-level effects of obesity on mortality in a single calendar year
but also hamper the construction of time series. First, the use of different methods over time makes it
difficult to construct time series of PAFs based on existing studies. Second, data limitations can also
pose challenges when estimating time series. In particular, more advanced PAF methods require data
that simply are not consistently available over a longer time period (see Supplementary Material file1).
To date, only one previous study has examined the long-term trends in obesity-attributable mortality
and did so for Canada using an all-cause approach [19]. In addition, the GBD study estimates mortality
due to high BMI every five years from 1990 to 2015 [20]. Because the GBD study is updated regularly
based on the latest research findings, it is unclear whether the same methodology was applied and the
same cause-of-death and RR data were used in each update [20,21].
Previous research on obesity-attributable mortality has focused on the United States [11,13,
15] in part because of the availability of large cohort studies for the US as a whole. For Europe,
by contrast, there is little available information on obesity-attributable mortality levels and even less
information on trends. To the best of our knowledge, the influence of the chosen method on estimates
of obesity-attributable mortality trends has not previously been assessed.
Our objective is to assess the impact of the use of different estimation techniques on both the
levels of and the trends in obesity-attributable mortality. More specifically, we compare approaches
that can actually be used to estimate the long-term trends given the data that are available for the
European context: namely, the partially adjusted method, the weighted sum method, a combined
version of these methods, and the CRA approach. To enable this comparison, we adapted the CRA
approach so that it calculates the PAF related to obesity only.
2. Materials and Methods
2.1. Methods for Calculating Obesity-Attributable Mortality
Below we present the different PAF formulas that we will use to estimate the obesity-attributable
mortality fraction (OAMF).
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2.2. Selected All-Cause Approaches
We follow the terminology of a partially adjusted and weighted sum method, as described by
Flegal [15]. The partially adjusted method and the weighted sum method [15,16] are both all-cause
approaches (see Supplementary Material file 1) that use the same PAF equation.
PAF =
P·(RR− 1)
1 + P·(RR− 1) (1)
where P is the proportion of the population exposed to obesity and RR is the (unadjusted) relative risk
of mortality associated with obesity [14]. The partially adjusted method combines one overall adjusted
RR of dying from obesity with the observed overall obesity prevalence. The weighted sum method
uses unadjusted subgroup-specific RRs and subgroup-specific prevalence.
In fact, the weighted sum method commonly uses a modified version of Equation (1), which
distinguishes multiple categories of the exposure variable such as different age groups.
PAF = ∑
Pi·(RRi − 1)
1 + ∑Pi·(RRi − 1) (2)
where i refers to the ith exposure category.
In addition to the above-mentioned approaches, we also used a combined all-cause approach in
which we used age-specific and sex-specific obesity prevalence and age-adjusted and sex-specific RRs
in Equation (2). A single PAF value is achieved through weighting by sex.
2.3. Comparative Risk Assessment (CRA) Approach
The Comparative Risk Assessment Approach (CRA) (terminology following Flegal [17]) estimates
the number of cause-specific deaths that would be prevented if the current BMI distributions were
changed to a hypothetical alternative distribution: the so-called counterfactual distribution [22].
We rewrote Equation (2) to show more intuitively how this approach calculates mortality attributable





where p1 refers to the observed BMI distribution (the factual distribution), p2 to the counterfactual
distribution, and RRi to the cause-specific relative risk of mortality for the exposure level i.
2.4. Adjustment of the CRA Approach
To estimate deaths attributed to obesity only (BMI ≥ 30 kg/m2), we adjusted the CRA calculation
to the following equation.
PAFBMI≥30 =
∑BMI≥30 p1i·RRi −∑BMI≥30 p2i·RRi
∑∞i=0 p1i·RR
(4)
i.e., we limited the numerator to categories with BMI 30+ while the denominator contains all
BMI categories so that the resulting fraction can be multiplied by the total deaths in a country.
As counterfactual, we used the BMI range between 21 and 23 kg/m2 [20,21].
2.5. Data Sources
2.5.1. BMI Data
Obesity prevalence and BMI distribution (i.e., Mean ± Standard Deviation) data required for
the all-cause and the CRA approaches, respectively, were obtained from the Dutch Health Interview
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Survey [23] from Statistics Netherlands. This is a nationally representative on-going study based on
self-reported weight and height covering the period between 1981 and 2013 [23,24].
2.5.2. Mortality Data
All-cause mortality data by sex, age group (30–75+), and year (1981 to 2013) were obtained from
the Human Mortality Database (HMD) [25] and were used for all the approaches.
For the adjusted CRA approach, we obtained cause-specific mortality data by sex and age from
the World Health Organization (WHO) Mortality Database [26]. In fact, we used two different sets of
death causes and associated RRs (see Table 1) and—consequently—distinguish between two adjusted
CRA approaches: adjusted CRA recent and adjusted CRA less recent. See Table 1 for the causes of
death used in these two adjusted CRA approaches.
Table 1. Causes of death used in the two adjusted CRA approaches and the associated RRs ranging
from ages 50 to 54.
Adjusted CRA Less Recent Adjusted CRA Recent
Danaei et al. 2009 * Relative Risks GBD 2013 ** Relative Risks
Causes of Death Men Aged50–54
Women Aged





Colon and rectum cancers 1.04 1.02 Colon and rectum cancers 1.03 1.01
Breast cancer - 1.02 Breast cancer - 1.02
Corpus uteri cancer - 1.10 Corpus uteri cancer - 1.10
Diabetes mellitus 1.20 1.20 Diabetes mellitus 1.21 1.21
Hypertensive heart disease 1.18 1.18 Hypertensive heart disease 1.18 1.18
Ischemic heart disease 1.09 1.09 Ischemic heart disease 1.09 1.09
Cerebrovascular disease 1.10 1.10 Cerebrovascular disease 1.10 1.10
Kidney cancer 1.05 1.05 Kidney cancer 1.04 1.06
Pancreatic cancer 1.01 1.02 Pancreatic cancer 1.01 1.02
Esophageal cancer 1.07 1.06
Liver cancer 1.05 1.03
Gallbladder cancer 1.03 1.06
Leukemia 1.02 1.02
* The causes of death we included are the same as those listed by Danaei 2009 [22] except that we did not
include non-Hodgkin lymphoma. ** The GBD 2013 also uses the following causes of death: hemorrhagic stroke,
cardiomyopathy, atrial fibrillation, aortic aneurysm, peripheral vascular endocarditis, other cardiovascular disease,
diabetes, chronic kidney disease (CKD), glomerulonephritis CKD, other CKD, hypertensive CKD, ovarian cancer,
and thyroid cancer [21]. However, because our study period covers causes of death classified by both ICD-9 and
ICD-10 and some of the abovementioned detailed causes of death were not available from the WHO mortality
database, we restricted ourselves to the causes of death listed here.
2.6. Relative Risks (RRs)
Since unadjusted RRs are not readily available, we had to include adjusted RRs for the
all-cause approaches, which has been done previously [10,11]. From the meta-analysis by Flegal
et al., we obtained worldwide and European overall RRs—adjusted for (at least) age and sex—and
sex-specific RRs [27]. From the meta-analysis by Wang, we obtained age-specific and sex-specific
worldwide RRs [28]. From the Dynamo project [29], which is based on a comprehensive literature
review, we obtained European age-specific and sex-specific RRs (see Table 2).
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Table 2. RRs used in the all-cause approach and their characteristics.




Partially adjusted Worldwide All adult ages 1.18 Flegal et al. 2013 [27]
Partially adjusted Europe All adult ages 1.27 Flegal et al. 2013 [27]
Combined approach Worldwide All adult ages 1.27 1.25 Flegal et al. 2013 [27]
Weighted sum method Europe
<50 1.55 1.5
Lobstein & Leach 2010 [29]50–59 1.539 1.4960–69 1.5225 1.475
70+ 1.495 1.45
Weighted sum method Worldwide







For our adjusted CRA approach, we used cause-specific, sex-specific, and age-specific RRs provided by the GBD
2013, which are worldwide RRs based on a meta-analysis [21] (recent RRs). In addition, we identified previously
published worldwide RRs based on a meta-analysis [22] (less recent RRs) (see Table 1).
3. Results
The different approaches generated different estimates of the OAMFs for The Netherlands in 2013
(see Table 3). Using worldwide RRs, the weighted sum method provided the lowest estimates for men
and women combined (0.92%) and for men (0.86%). However, the partially adjusted method provided
a slightly lower estimate for women (0.94%) than the weighted sum method (0.98%). The adjusted CRA
approach using the 2013 world RRs generated the highest estimates for men and women combined
(1.46%) and for women (1.62%) while the combined all-cause method using the world RRs provided
the highest estimate for men (1.43%). The use of European-specific RRs instead of worldwide RRs
resulted in higher estimates. The weighted sum method using the European-specific RRs resulted in
the highest estimates overall (1.78%).
Table 3. Estimates of the percentage of deaths attributed to obesity by method and sex in The
Netherlands in 2013.
Approach Men Women Men and Women
Partially adjusted – world 0.97 0.94 1.00
Partially adjusted – Europe 1.45 1.37 1.41
Weighted sum method – world 0.86 0.98 0.92
Weighted sum method – Europe 1.88 1.68 1.78
Combined all-cause method – world 1.43 1.29 1.37
Adjusted CRA, recent – world 1.29 1.62 1.46
Adjusted CRA, less recent – world 1.21 1.48 1.35
Overall, the different approaches—with the exception of the results for women generated by the
CRA approaches—showed that the OAMF levels increased over the period 1981 to 2013 and especially
from 1993 onwards (see Figure 1, Table 4). For men, the trends are parallel for the different approaches
even though, in terms of the percentage change, the CRA approaches resulted in larger overall increases
(>75%) (Table 4) than the all-cause approaches (around 50%). For women, the trends identified by
the adjusted CRA approaches clearly differed from those found by the other approaches. Over the
period 1981 to 2013, both the adjusted CRA approach with recent RRs and the adjusted CRA with less
recent RRs resulted in a decline (−1.7% and −9.6%, respectively) as well as with a slight increase from
1993 onwards (4.3% and 0.7%, respectively). For women, the other approaches estimated the overall
percentage increase at around 85% even though the partially adjusted method using European RRs
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resulted in a larger increase (133%) and the weighted sum method using worldwide RRs in a smaller
increase (63%). When applied to men and women combined (Figure S1), the partially adjusted method
and the weighted sum method produced very similar levels and trends from 1993 onwards. The same





Figure 1. Estimates of the percentage of deaths attributed to obesity in The Netherlands using 
worldwide RRs from 1981 to 2013. 
Table 4. Percentage change in obesity-attributable mortality fractions (OAMF) from 1981–1993, 1993–
2013, and 1981–2013 in The Netherlands by sex. 
Change in OAMF (%) 1981–1993 1993–2013 1981–2013 
Men    
Partially adjusted - world  −19.1% 78.7% 44.5% 
Partially adjusted – Europe −14.8% 73.2% 47.5% 
Weighted sum method – world 2.3% 49.3% 52.7% 
Weighted sum method – Europe −13.6% 74.4% 50.6% 
Combined all-cause method – world −19.2% 77.8% 43.6% 
Adjusted CRA recent – world 25.3% 56.4%% 96.0% 
Adjusted CRA less recent – world 19.5% 48.9% 77.9% 
Women    
Partially adjusted - world  0.26% 85.9% 86.4% 
Partially adjusted – Europe 31.5% 77.1% 133.0% 
Weighted sum method – world −4.8% 70.8% 62.6% 
Weighted sum method – Europe 2.1% 79.5% 83.3% 
Combined all-cause method – world 0.2% 85.2% 85.6% 



























































Adjusted CRA recent –
world























































Adjusted CRA recent –
world
Adjusted CRA less 
recent – world
Figure 1. Estimates of the percentage of deaths attributed to obesity in The Netherlands using
worldwide RRs from 1981 to 2013.
Table 4. Percentage change in obesity-attributable mortality fractions (OAMF) from 1981–1993,
1993–2013, and 1981–2013 i e Netherlands by sex.
Change in OAMF (%) 1981–1993 1993–2013 1981–2013
Men
Partially adjusted - world −19.1% 78.7% 44.5%
Partially adjusted – Europe −14.8% 73.2% 47.5%
Weighted sum ethod – world 2.3% 49.3% 52.7%
Weighted sum me hod – Europe −13.6 74.4% 50.6%
Combined all-cause meth d – world −19.2 77.8% 43.6%
Adjusted CRA recent – world 25.3% 56.4%% 96.0%
Adjusted CRA l ss recent – world 19.5% 48.9% 77.9%
Women
Partially adjusted - world 0.26% 85.9% 86.4%
Partially adjusted – Europe 31.5% 77.1% 133.0%
Weighted sum method – world −4.8% 70.8% 62.6%
Weighted sum method – Europe 2.1% 79.5% 83.3%
Combined all-cause method – world 0.2% 85.2% 85.6%
Adjusted CRA recent – world −5.8% 4.3% −1.7%
Adjusted CRA less recent – world −10.3% 0.7% −9.6%
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4. Discussion
4.1. Summary of Results
The different approaches to estimate obesity-attributable mortality fractions (OAMFs) for
The Netherlands in 2013 led to a range of estimates. The weighted sum method using worldwide RRs
generated the lowest values (0.9%) while the adjusted CRA approach using 2013 RRs generated the
highest estimate (1.5%). Using European-specific RRs instead of worldwide RRs resulted in higher
estimates. Most of the approaches revealed an increasing OAMF over the period 1981 to 2013 especially
from 1993 onwards. However, the adjusted CRA approach showed that there was hardly any increase
among women.
4.2. Explanation of the Observed Results
The different approaches we applied—i.e., the partially adjusted method, the weighted sum
method, the combined all-cause method, and the adjusted CRA approach—provided different
estimates of obesity-attributable mortality. These findings further corroborate previous research
showing that PAF estimates vary widely, according to the methodology used [18]. The plausible
explanations for our finding that the estimates produced by the CRA approaches were higher than
the estimates generated by the partially adjusted method and the weighted sum method lie not only
in the methodology employed but also in the different underlying data and RRs used. Specifically,
in the all-cause approaches, obesity prevalence, all-cause mortality data, and all-cause RRs [15] are
used while, in the adjusted CRA approach, more detailed information is used including data on the
whole BMI distribution, cause-specific mortality, and the cause-specific RRs [30]. It appears that the
combined all-cause method was able to produce similar results based on less detailed information.
Our finding for 2013 that the weighted sum method produced lower OAMF estimates when
worldwide RRs are used seems to be in line with the results of a study conducted in the US in 1991,
which showed that the partially adjusted method generated an OAMF estimate that was 17% higher
than the estimate produced by the weighted sum method [15]. The explanation given by the researchers
is that the partially adjusted method does not fully account for confounding and effect modification
by age and sex. It should be noted, however, that, in our analysis, the RRs for the partially adjusted
method and the weighted sum method did not come from the same study. This most likely explains
why the partially adjusted method actually produced lower estimates than the weighted sum method
when the European RRs were used.
In our study, the use of European RRs resulted in higher estimates than the use of worldwide RRs
within the same method primarily because the European RR values were higher than the worldwide
RR values (see Table 2). Additionally, in previous literature, European RR values were reported to be
higher than those from North America, East Asia, Australia, and New Zealand [10,20,27]. While no
clear explanation of these differences in RR values has been provided in the available literature, it most
likely follows the notion that RRs could be different for some disease and all-cause mortality across
geographical contexts [29,31]. In other words, the differences in RR values across populations are likely
related to variation in dietary [32], disease, and mortality patterns and in the genetic background [33].
In our study, all of the approaches (except of the adjusted CRA approach for women) revealed
an increase in obesity-attributable mortality levels especially from 1993 onwards. These findings
are in line with the results of previous studies of obesity prevalence and BMI mean values for
The Netherlands, which showed that obesity prevalence increased sharply after the 1990s (see Figure
S2) [24]. In addition, the accelerated increase is in line with the observations for other European adult
cohort populations [34]. Taken together, these findings seem to indicate that the obesity epidemic is
accelerating in The Netherlands and other European populations. It should be noted, however, that
the GBD study found that the trend in mortality due to high BMI in The Netherlands was decreasing
over the 1990–2013 period. This seemingly contradictory finding is most likely related to the indirect
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estimation by the GBD of mean BMI values over time. The declining trend that was found using their
indirect estimation [35] does not reflect the actual observed trend in The Netherlands [24].
For women, the adjusted CRA approach clearly resulted in different trends compared to the other
approaches with a decline over the period 1990 to 2013. Since these differences were not observed
for men, the reason for this finding seems to lie less in the methodology that was applied than in the
sex-specific data that were used. Since the RRs do not change over time and are fairly similar for men
and women (see Table 1), the trends in mean BMI and the trends in cause-specific mortality are more
decisive. Specifically, we found that the mean BMI values of women have increased less than the mean
BMI values of men in all age groups (see Figure S3). Moreover, when we looked at the trends for
ischemic and cerebrovascular heart disease, which represent around 70% of the changes in mortality in
both sexes, we found that, after 1993 ischemic and cerebrovascular mortality declined more among
women than among men.
4.3. Reflection on Our Approach
When aiming to compare the different methodologies to estimate obesity-attributable mortality
and their estimates concerning Europe, data availability is a major restricting factor. Related to
this, we chose a practical and rather straightforward evaluation strategy where we compared the
methodologies that can practically be applied with the available data and their point estimates.
Each available method requires a different level of detail with regard to the RRs (by age group or
not, by cause of death or not). Unfortunately, a dataset providing all the RRs needed is not available.
Instead, we, like previous studies, had to rely on RRs from different data sources/meta-analyses for
each method [18], which is likely to have an impact on our results. The comparison of levels is likely to
generate different outcomes (different differences) when, in a simulation study, hypothetical RRs from
one source are used. The comparison of trends will, however, likely be much less affected because
distorting factors presumably lead to larger RR differences between sources than within sources over
time. More importantly, however, when the method is applied in practice, it will do so based on the
available RRs.
In addition, we chose not to estimate confidence intervals surrounding the RRs. First, due to
using secondary data (from different sources, and both for RR and prevalence), we do not possess the
covariance matrix of the relevant variables. Hence, a formal comparison of levels or trends cannot
be made unless untestable assumptions—which will affect the comparisons—are also made [18].
Second, in standard frequentist approaches, confidence intervals cannot capture all the uncertainty
surrounding the estimation of obesity-attributable mortality. For instance, they cannot assess the
uncertainty regarding the choice of the RR. Thirdly, policy makers, public health professionals, and
researchers working on obesity-attributable mortality in Europe mostly use point estimates.
Although we used a fairly simple evaluation approach, it is still the first time that the influence
of the chosen method (and the related RRs) on obesity-attributable mortality trends for a European
country has been assessed. In doing so, our study provided valuable insights into the pros and cons of
the different methods and highlighted as well the urgency for additional data in Europe.
4.4. Reflection on the Different Methodologies
We applied methodologies that, based on their data requirements, enabled us to construct
time series of the OAMF. We included three all-cause approaches: the partially adjusted method,
the weighted sum method, and a combined all-cause method. The partially adjusted method requires
the least amount of detailed data. However, because of the scarcity of unadjusted RRs, most studies
that have applied this method (including our study) used adjusted RRs instead [10,11], which can
produce biased estimates [15]. To limit this bias, we used the combined all-cause method, which
enabled us to weigh by sex. We also applied the weighted sum method, which allowed us to take into
account both confounding and effect modification by age and sex using age-specific and sex-specific
RRs. As the weighted sum method deals with confounding and effect modification better than the
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other all-cause methods we examined, it seems to be the most appropriate method to use for the
estimation of OAMF. In fact, the results produced by the weighted sum method using European RRs
were close to the results generated in 2013 by the adjusted CRA method.
In addition, we applied the CRA approach, which we adjusted to estimate the share of mortality
due to obesity only. An advantage of the CRA approach is that it has the potential to provide
more reliable estimates because it takes more information into account such as information on the
obesity-related causes of death. One disadvantage of the CRA approach is that it requires the BMI
distribution and data on (detailed) causes of death, which are not readily available for European
countries. This issue is especially salient when aiming to study time trends. In addition, the changes
in the ICD classification over time [36] make it difficult to obtain the complete list of causes of death
associated with obesity over time.
Given these considerations, we recommend the use of the weighted sum method for the study of
trends in OAMFs for the European context and ideally the provision of confidence intervals.
5. Conclusions
Estimates of both the levels of, and the trends in, obesity-attributable mortality fractions in
The Netherlands differed depending on the method applied as well as on the underlying data and
the relative risks (RRs) used. Since obesity prevalence is relatively low in The Netherlands, we would
expect to find even larger differences for countries with higher obesity prevalence. In quantifying
the health burden of obesity at the population level, it is, therefore, essential to compare different
methodologies and different RRs.
Comparisons of obesity-attributable mortality between countries and over time can only be
performed accurately by using the same methodology as well as comparable data and RRs. Since
the data that are currently available for Europe are limited, we recommend using the weighted-sum
method and European RRs to compare obesity-attributable mortality across European countries and
over time.
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